Fulgent Genetics (FLGT) Non Operating Income (2023 - 2026)

Fulgent Genetics has disclosed Non Operating Income across 4 years of filings, most recently posting $8.6 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $8.6 million, up 12611.76% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.3 million (up 24.77% YoY), and the FY2025 annual result was $153000.0, down 72.73% from the prior year.
• Non Operating Income came in at $8.6 million for Q1 2026 at Fulgent Genetics, up from -$14.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $21.1 million in Q4 2023 to a low of -$14.0 million in Q4 2025.
• The 4-year median for Non Operating Income is $46000.0 (2025), against an average of $1.4 million.
• Across the five-year window, Non Operating Income slumped 163.08% in 2024 and surged 12611.76% in 2026, its largest moves.
• Fulgent Genetics' Non Operating Income stood at $21.1 million in 2023, then tumbled by 163.08% to -$13.3 million in 2024, then decreased by 4.83% to -$14.0 million in 2025, then surged by 161.95% to $8.6 million in 2026.
• The last three Non Operating Income figures came in at $8.6 million (Q1 2026), -$14.0 million (Q4 2025), and -$5000.0 (Q3 2025), per Business Quant data.